HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew Lyne Selected Research

Guanfacine (Tenex)

1/2016Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study.
11/2015Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial.
11/2015A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder.
12/2014Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial.
10/2014Efficacy of guanfacine extended release assessed during the morning, afternoon, and evening using a modified Conners' Parent Rating Scale-revised: Short Form.
1/2012A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder.
4/2011Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder.
9/2010Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.
6/2009Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
2/2009Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew Lyne Research Topics

Disease

18Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2016 - 04/2007
2Disorders of Excessive Somnolence (Hypersomnia)
04/2011 - 09/2010
2Sleepiness
04/2011 - 09/2010
2Lethargy
04/2011 - 09/2010
2Fatigue
04/2011 - 09/2010
2Headache (Headaches)
09/2010 - 04/2007
2Ulcerative Colitis
01/2007 - 01/2007
1Postural Orthostatic Tachycardia Syndrome
06/2021
1Asthenia
09/2010
1Abdominal Pain (Pain, Abdominal)
09/2010
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2005
1Polycythemia Vera
05/2005
1Myeloproliferative Disorders (Myeloproliferative Disorder)
05/2005
1Leukemia
05/2005
1Essential Thrombocythemia
05/2005

Drug/Important Bio-Agent (IBA)

15Guanfacine (Tenex)FDA LinkGeneric
01/2016 - 04/2007
3Lisdexamfetamine DimesylateFDA Link
06/2014 - 10/2013
2Delayed-Action PreparationsIBA
01/2008 - 09/2007
2Mesalamine (Mesalazine)FDA LinkGeneric
01/2007 - 01/2007
1IvabradineIBA
06/2021
1Methylphenidate (Ritalin)FDA LinkGeneric
12/2013
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
12/2013
1ProdrugsIBA
12/2013
1Hypnotics and Sedatives (Sedatives)IBA
04/2011
1anagrelide (Agrylin)FDA LinkGeneric
05/2005

Therapy/Procedure

3Therapeutics
12/2013 - 04/2007
1Ambulatory Care (Outpatient Care)
06/2009
1Remission Induction
01/2007
1Duration of Therapy
05/2005